Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent- infected cells in a murine model system

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 546-550

  Bunnell, Joseph E ^a   Trigiani, Ellen R ^c   Srinivas, S R ^c   Dumler, J Stephen ^a,b,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; EHRLICHIOSIS; HEMATOPOIETIC TISSUE; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNOCOMPETENCE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; EHRLICHIA; EHRLICHIOSIS; HUMANS; IMMUNOCOMPROMISED HOST; MICE; MICE, INBRED C3H; MICE, SCID; PEROMYSCUS; POLYMERASE CHAIN REACTION;

EID: 0033496779     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314902     Document Type: Article

References (15)

1. 1. Telford SR III, Dawson JE, Katavolos P, Warner CK, Kolbert CP, Persing DH. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci USA 1996; 93:6209-14.
2. 2. Hodzic E, IJdo JWI, Feng S, et al. Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis 1998; 177:737-45.
3. 3. Sun W, IJdo JW, Telford SR III, et al. Immunization against the agent of human granulocytic ehrlichiosis in a murine model. J Clin Invest 1997; 100:3014-8.
4. 4. Madigan JE, Richter PJ Jr, Kimsey RB, Barlough JE, Bakken JS, Dumler JS. Transmission and passage in horses of the agent of human granulocytic ehrlichiosis. J Infect Dis 1995; 172:1141-4.
5. 5. Bakken JS, Krueth JK, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996; 275:199-205.
6. 6. Dumler JS, Asanovich KM, Bakken JS, Richter P, Kimsey R, Madigan JE. Serologic cross-reactions among Ehrlichia equi, E. phagocytophila, and human granulocytic ehrlichia. J Clin Microbiol 1995; 33:1098-103.
7. 7. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994; 32:589-95.
8. 8. Edelman DC, Dumler JS. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagn 1996; 1:41-9.
9. 9. Bakken JS, Dumler JS, Chen SM, Eckman MR, Van Etta LL, Walker DH. Human granulocytic ehrlichiosis in the upper Midwest United States: a new species emerging? JAMA 1994; 272:212-8.
10. 10. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD. Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis 1990; 162:133-8.
11. 11. Barthold SW, Sidman CL, Smith AL. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg 1992; 47:605-13.
12. 12. Feng HM, Wen J, Walker DH. Rickettsia australis infection: a murine model of a highly invasive vasculopathic rickettsiosis. Am J Pathol 1993; 142: 1471-82.
13. 13. Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996; 334:209-15.
14. 14. Klein MB, Miller JS, Nelson CM, Goodman JL. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J Infect Dis 1997; 176:1405-9.
15. 15. Walker DH, Dumler JS. Human monocytic and granulocytic ehrlichioses: discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med 1997; 121:785-91.